Inventor · disambiguated record
Michael B. Yaffe
Also filed as: YAFFE MICHAEL · YAFFE MICHAEL B
11 granted patents·22 pending applications·46 citations·filing 1997–2024
88Inventor score
Files withMASSACHUSETTS INST TECHNOLOGY14YAFFE MICHAEL B8MAX PLANCK GESELLSCHAFT2MERRIMACK PHARMACEUTICALS INC2THROMBO THERAPEUTICS INC1
Top patents by PatentIndex Score
33 records- 0188US9566280B2Combination therapies and methods of use thereof for treating cancerMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Feb 14, 2017·4 cites·18 claims
- 0284US2025186462A1Combination therapies and methods of use thereof for treating cancerMASSACHUSETTS INST TECHNOLOGY·Filed 2024·Application pending·0 cites
- 0380US10155006B2Combination therapies and methods of use thereof for treating cancerMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Dec 18, 2018·1 cites·15 claims
- 0480US9023787B2MAPKAP kinase-2 as a specific target for blocking proliferation of P53-defectiveMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted May 5, 2015·3 cites·14 claims
- 0579US12115171B2Combination therapies and methods of use thereof for treating cancerMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Granted Oct 15, 2024·0 cites·20 claims
- 0679US9320750B2Compositions and methods of treatment of drug resistant cancersMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Apr 26, 2016·3 cites·10 claims
- 0778US6462173B1Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerasesMAX PLANCK GESELLSCHAFT·Filed 1997·Granted Oct 8, 2002·27 cites·19 claims
- 0877US6730492B2Cell-based screening methodsMERRIMACK PHARMACEUTICALS INC·Filed 2002·Granted May 4, 2004·4 cites·4 claims
- 0976US2024360492A1Coagulation and fibrinolysis assaysMASSACHUSETTS INST TECHNOLOGY·Filed 2024·Application pending·0 cites
- 1071US10772898B2Combination therapies and methods of use thereof for treating cancerMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Sep 15, 2020·0 cites·21 claims
- 1169US2021030771A1Combination therapies and methods of use thereof for treating cancerMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Application pending·0 cites
- 1268US9610332B2Compositions and methods for modulating BRD4 bioactivityMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Apr 4, 2017·2 cites·30 claims
- 1364US7083938B2Cell-based screening methodsMERRIMACK PHARMACEUTICALS INC·Filed 2004·Granted Aug 1, 2006·0 cites·5 claims
- 1459US2023263783A1Cancer treatment by combined inhibition of polo-like kinase and microtubule polymerizationMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Application pending·0 cites
- 1558US8440610B2Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cellsYAFFE MICHAEL B·Filed 2007·Granted May 14, 2013·2 cites·14 claims
- 1656US2009181468A1Methods and compositions for treating cellular proliferative diseasesYAFFE MICHAEL B·Filed 2008·Application pending·0 cites
- 1755US2010030543A1Products and processes for modulating peptide-peptide binding domain interactionsYAFFE MICHAEL B·Filed 2008·Application pending·0 cites
- 1855US2020208194A1Coagulation and fibrinolysis assaysMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Application pending·0 cites
- 1955US2003109423A1Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerasesMAX PLANCK GESELLSCHAFT·Filed 2002·Application pending·0 cites
- 2053US2021154281A1Cell-based cancer vaccines and cancer therapiesMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Application pending·0 cites
- 2151US2022127682A1Selection and treatment of cancer with combination therapiesMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Application pending·0 cites
- 2251US2009143997A1Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1YAFFE MICHAEL B·Filed 2008·Application pending·0 cites
- 2349US2005196808A1Products and processes for modulating peptide-peptide binding domain interactionsFiled 2003·Application pending·0 cites
- 2448US2011104713A1Products and processes for modulating peptide-peptide binding domain interactionsYAFFE MICHAEL B·Filed 2010·Application pending·0 cites
- 2547US2006115453A1Methods and compositions for treating cellular proliferative diseasesYAFFE MICHAEL B·Filed 2005·Application pending·0 cites
- 2646US2003170850A1Cell-based screening methodsFiled 2002·Application pending·0 cites
- 2745US2012295802A1Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1YAFFE MICHAEL B·Filed 2012·Application pending·0 cites
- 2841US2002192711A1Methods for identifying ligands of G-Protein-Coupled receptorsFiled 2002·Application pending·0 cites
- 2941US2003170611A1Cell-based screening methodsFiled 2002·Application pending·0 cites
- 3041US2006052951A1Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1YAFFE MICHAEL B·Filed 2005·Application pending·0 cites
- 3141US2020129448A1Compositions and methods for wound closureTHROMBO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3234US2003148377A1Binding compounds and methods for identifying binding compoundsFiled 2001·Application pending·0 cites
- 3324US2002068301A1Cyclic peptide libraries and methods of use thereof to identify binding motifsFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael B. Yaffe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →